NOV:ETR
Novo Nordisk A/S
33,92 €
arrow_downward
-1,08%(-0,37) 1K
14-okt, 13:33:08 (GMT+2) · EUR
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoNOV tikeri uchun statistika yaratilmoqda...
Ochish
33,96 €
Yuqori
34,08 €
Past
33,90 €
Bozor kapitali
128,51 mlrd
Oʻrtacha hajm
179,02 ming
Hajmi
47,39 ming
52 haftalik eng yuqori
54,87 €
52 haftalik eng past
30,24 €
Xodimlar soni
67 ming
Ochish
33,96 €
Yuqori
34,08 €
Past
33,90 €
Bozor kapitali
128,51 mlrd
Oʻrtacha hajm
179,02 ming
Hajmi
47,39 ming
52 haftalik eng yuqori
54,87 €
52 haftalik eng past
30,24 €
Xodimlar soni
67 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
ad-hoc-news.de
·
35 daqiqa oldin
BMO cuts target for Novo Nordisk stock to USD 40.00
ad-hoc-news.de
·
5 soat oldin
Novo Nordisk stock pre-market at EUR 33.91
Traders Union
·
7 soat oldin
India emerges as a key hub in pharmaceutical companies’ anti-obesity business and research strategy
The Motley Fool
·
13 soat oldin
AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?
Profil
Novo Nordisk A/S, doing business as Novo, is a Danish multinational pharmaceutical company. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds 28% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. Wikipedia
Novo Nordisk A/S haqida
CEOMaziar Mike Doustdar
Xodimlar soni66,7 ming
Asos solingan1923
Bosh ofislarBagsværd, Capital Region of Denmark, Daniya
Sektor-
Veb-saytnovonordisk.com